Distribuzione geografica
Continente #
NA - Nord America 1260
EU - Europa 1210
AS - Asia 629
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3108
Nazione #
US - Stati Uniti d'America 1248
CN - Cina 612
IE - Irlanda 505
IT - Italia 182
UA - Ucraina 161
DE - Germania 102
FI - Finlandia 94
GB - Regno Unito 48
SE - Svezia 43
FR - Francia 36
BE - Belgio 26
CA - Canada 12
IN - India 4
JP - Giappone 4
VN - Vietnam 4
BR - Brasile 3
NL - Olanda 3
RU - Federazione Russa 3
AU - Australia 2
EU - Europa 2
KR - Corea 2
MU - Mauritius 2
NO - Norvegia 2
RO - Romania 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
PH - Filippine 1
SG - Singapore 1
TR - Turchia 1
Totale 3108
Città #
Dublin 500
Chandler 396
Jacksonville 214
Nanjing 168
Beijing 112
Pavia 98
Ann Arbor 83
Princeton 73
Nanchang 69
Lawrence 68
Medford 62
Shenyang 56
Wilmington 56
Changsha 47
Jiaxing 40
Hebei 39
Hangzhou 27
Tianjin 27
Brussels 26
Boardman 23
Milan 22
Des Moines 14
Woodbridge 14
Helsinki 13
Toronto 11
Verona 11
San Francisco 9
Fairfield 8
Norwalk 8
Dearborn 5
Houston 5
Ashburn 4
Dong Ket 4
Jinan 4
Lucino 4
Ningbo 4
San Mateo 4
Kunming 3
Los Angeles 3
Nagold 3
Redmond 3
Redwood City 3
The Dalles 3
Auburn Hills 2
Berlin 2
Bologna 2
Changchun 2
Lissone 2
London 2
Melbourne 2
Oslo 2
Perugia 2
Serra 2
Taizhou 2
Andover 1
Anguillara 1
Borås 1
Brierley Hill 1
Cambridge 1
Chicago 1
Couilly-pont-aux-dames 1
Ercolano 1
Fremont 1
Groningen 1
Gunzenhausen 1
Hanover 1
Kemerovo 1
Lanzhou 1
Legnano 1
Lincoln 1
Manila 1
Narbonne 1
New York 1
Novokuznetsk 1
Ottawa 1
Reggio Calabria 1
Rezzato 1
Saint Petersburg 1
Seattle 1
Seoul 1
Serina 1
Simi Valley 1
Singapore 1
Sofia 1
Stafford 1
São Paulo 1
Timisoara 1
Tokyo 1
Viadana 1
Zhengzhou 1
Totale 2404
Nome #
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 89
Characterisation by Capillary Electrophoresis of wild type and new naturally amyloidogenic variant of beta2-microglobulin 82
Beta2-microglobulin and amyloidosis: separation and characterization of protein folding conformers 78
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 74
Integrated strategies for affinity-based screening: from binding to in silico studies 72
Derivati antracenedionici e aza-antracenedionici come agenti capaci di inibire l’aggregazione di peptidi beta amiloidi 70
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 70
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 69
Capillary Electrophoresis as a specific tool to assess the targeting of oligomers along the formation of amyloid fibrils. 64
A bis-tacrine derivative inhibits abeta-protein oligomerization and fibrillogenesis 64
Artichoke (Cynara cardunculus L. var. scolymus) waste as a natural source of carbonyl trapping and antiglycative agents 64
Discovery of Abeta protein fibrillogenesis inhibitors by using CE. 62
Analysis and characterization of proteins and protein complexes by Flow- field Flow Fractionation with Multi-Angle Laser Scattering Detection 62
Capillary electrophoresis can assess the effect of a bis-tacrine derivative on Abeta-protein oligomerization 62
Characterization of different variants of beta2-microglobulin by capillary electrophoresis and high-resolution mass spectrometry 61
Capillary electrophoresis, mass spectrometry and in silico studies: a multidisciplinary approach for drug discovery 60
CE can identify small molecules that selectively target soluble oligomers of Abeta 1-42 peptide and display antifibrillogenic activity 60
Cretan tea (Origanum dictamnus L.) as a functional beverage: an investigation on antiglycative and carbonyl trapping activities 59
Mass spectrometry and affinity capillary electrophoresis: an integrated approach for rapid screening of protein-drug binding 57
Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies 57
Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound 57
A Combined High Resolution Mass Spectrometric and in Silico Approach for the Characterisation of Small Ligands of β2-microglobulin 57
Studio della fibrillogenesi di peptidi β-amiloidi mediante frazionamento in campo di flusso-flusso con rivelazione multiangle laser scattering. 56
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers 56
Drugs targeting transient protein conformers along the fibrillogenic pathway 55
Capillary electrophoresis in vitro separation of Abeta oligomers as drug targets: the sample preparation issue 54
Covalent modification of beta2-microglobulin induced by reactive carbonyl species: high resolution mass spectrometric studies 52
Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry 51
Regions and factors involved in conformational fluctuations of intact and dialysis-associated variants of beta2-microglobulin 50
Integrated strategies for drug discovery: capillary electrophoresis, mass spectrometry and in silico studies 50
The potential of capillary electrophoresis in the study of amyloidoses 49
Capillary Electrophoresis: an analytical strategy to evaluate the effects of small molecules on the toxic aggregates of Alzheimer’s disease 49
Evidence that the human innate immune peptide LL-37 may be a binding partner of amyloid-beta and inhibitor of fibril assembly 49
A new MS compatible HPLC-UV method for Teicoplanin drug substance and related impurities, part 1: Development and validation studies 48
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 47
Disease modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation 47
Separation and characterisation of beta2-microglobulin folding conformers by ion-exchange liquid chromatography and ion-exchange liquid chromatography-mass spectrometry 47
Lack of prolidase causes a bone phenotype both in human and in mouse 47
Folding intermediates and transient oligomers: difficult protein targets to find new drugs for amyloidoses 45
Optimisation of CE-ESI-MS platform for intact protein analysis: conformational studies on beta2-microglobulin. 44
Advances on Size Exclusion Chromatography and Applications on the Analysis of Protein Biopharmaceuticals and Protein Aggregates: A Mini Review. 44
Screening of Fibrillogenesis Inhibitors of β2-microglobulin: Integrated Strategies by Mass Spectrometry, Capillary Electrophoresis and in Silico Simulations 44
Leveraging on nanomechanical sensors to single out active small ligands for beta2-microglobulin 42
Capillary electrophoresis separation of metastable intermediates of amyloid protein fibrillogenesis to use them as independent targets for small molecules. 42
In vitro Amyloid Aβ1-42 Peptide Aggregation Monitoring by Asymmetrical Flow Field-Flow Fractionation with Multi-Angle Light Scattering Detection. 41
An outlook on the role of decaffeinated coffee in neurodegenerative diseases 39
A new millifluidic-based gastrointestinal platform to evaluate the effect of simulated dietary methylglyoxal intakes 38
Avocado (Persea americana Mill.) by-products and their impact: from bioactive compounds to biomass energy and sorbent material for removing contaminants. A Review 36
Reference Protocol to Assess Analytical Performance of Higher Order Structural Analysis Measurements: Results from an Interlaboratory Comparison 36
Screening of fibrillogenesis inhibitors of beta2-microglobulin: integrated strategie by MS, CE and docking Studies 35
Application of an HPLC-MS/MS method for Teicoplanin drug substance and related impurities, part 2: Identity assignment of related impurities 35
Selection and Optimization of an Innovative Polysaccharide-Based Carrier to Improve Anthocyanins Stability in Purple Corn Cob Extracts 35
Advances in the analysis of veterinary drug residues in food matrices by capillary electrophoresis techniques 33
Colored Corn: An Up-Date on Metabolites Extraction, Health Implication, and Potential Use 32
Chromatographic tools for plant-derived recombinant antibodies purification and characterization 30
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs 29
Advances in static: In vitro digestion models after the COST action Infogest consensus protocol 27
Pre-Concentration and Analysis of Mycotoxins in Food Samples by Capillary Electrophoresis 26
Bioactivities and in silico study of Pergularia tomentosa L. phytochemicals as potent antimicrobial agents targeting type IIA topoisomerase, TyrRS, and Sap1 virulence proteins 25
The influence of Cu2+ on the unfolding and refolding of intact and proteolytically processed β2-microglobulin. 24
Food aroma compounds by Capillary Electrophoresis 24
Phytochemical profiling of aqeous methanolic leaf extract of Triclisia gilletii by gas chromatography (GC/MS) and liquid chromatography (HPLC-PDA–ESI/MSn) tandem mass spectroscopy (MS): a pointer to its nephroprotection 24
Decaffeinated coffee and its benefits on health: focus on systemic disorders 22
A new Italian purple corn variety (Moradyn) byproduct extract: antiglycative and hypoglicemyc in vitro activities and preliminary bioaccessibility studies 21
Analytical settings for in-flow biocatalytic reaction monitoring 20
High-performance capillary electrophoresis for food quality evaluation 19
A New Polysaccharide Carrier Isolated from Camelina Cake: Structural Characterization, Rheological Behavior, and Its Influence on Purple Corn Cob Extract’s Bioaccessibility 19
Stem-like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-cancer Drugs 18
Recovery of chlorogenic acids from agri-food wastes: Updates on green extraction techniques 15
Development of an Accelerated Stability Model to Estimate Purple Corn Cob Extract Powder (Moradyn) Shelf-Life 14
Natural carriers: Recent advances in their use to improve the stability and bioaccessibility of food active compounds 11
Effect of the simulated digestion process on the chlorogenic acid trapping activity against methylglyoxal 9
Valorization of rice husk (Oryza sativa L.) as a source of in vitro antiglycative and antioxidant agents 9
Antiviral activity of Inonotusin A an active compound isolated from Boletus bellinii and Boletus subtomentosu 8
null 3
Totale 3275
Categoria #
all - tutte 6679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6679

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201847 0000 00 00 04520
2018/2019149 13524 81 386 31302
2019/2020792 203291332 637 636 22115392
2020/2021405 44342243 643 1162 41533610
2021/2022462 951210 711 824 19793257
2022/20231225 131971486 105111 481 596000
Totale 3275